SAM
SRPT icon

Storebrand Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Storebrand Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-157
Closed -$3.02K – 819
2025
Q3 		$3.02K Hold
157
– – ﹤0.01% 804
2025
Q2 		$2.69K Hold
157
– – ﹤0.01% 806
2025
Q1 		$10K Hold
157
– – ﹤0.01% 810
2024
Q4 		$19.1K Hold
157
– – ﹤0.01% 804
2024
Q3 		$19.6K Hold
157
– – ﹤0.01% 835
2024
Q2 		$24.8K Hold
157
– – ﹤0.01% 832
2024
Q1 		$20.3K Hold
157
– – ﹤0.01% 839
2023
Q4 		$15.1K Sell
157
-62
-28% -$5.95K ﹤0.01% 845
2023
Q3 		$26.5K Hold
219
– – ﹤0.01% 841
2023
Q2 		$25.1K Sell
219
-7,340
-97% -$946K ﹤0.01% 839
2023
Q1 		$1.04M Sell
7,559
-9,309
-55% -$1.21M 0.01% 676
2022
Q4 		$2.19M Sell
16,868
-4,426
-21% -$513K 0.01% 590
2022
Q3 		$2.35M Sell
21,294
-14,121
-40% -$1.42M 0.01% 565
2022
Q2 		$2.65M Hold
35,415
– – 0.02% 567
2022
Q1 		$2.77M Sell
35,415
-3,241
-8% -$248K 0.01% 575
2021
Q4 		$3.48M Sell
38,656
-11,847
-23% -$1.01M 0.02% 566
2021
Q3 		$4.67M Sell
50,503
-15,577
-24% -$1.2M 0.02% 529
2021
Q2 		$5.14M Sell
66,080
-11,296
-15% -$856K 0.03% 506
2021
Q1 		$5.77M Buy
77,376
+10,020
+15% +$925K 0.03% 474
2020
Q4 		$11.5M Buy
67,356
+42,653
+173% +$6.32M 0.07% 319
2020
Q3 		$3.47M Sell
24,703
-710
-3% -$108K 0.02% 512
2020
Q2 		$4.07M Buy
25,413
+8,132
+47% +$1.11M 0.03% 440
2020
Q1 		$1.69M Buy
+17,281
New +$1.98M 0.02% 557

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Storebrand Asset Management's SRPT Position: Q4 2025 in Review

Storebrand Asset Management sold out of Sarepta Therapeutics (SRPT) in Q4 2025, closing a stake of 157 shares — an estimated $3.02K sold.

Storebrand Asset Management first reported a position in SRPT in Q1 2020 and held it in 23 quarters. The position peaked at $11.5M in Q4 2020. 344 funds tracked by Wall St. Rank hold SRPT as of Q4 2025.

  • Storebrand Asset Management reported no remaining Sarepta Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Storebrand Asset Management sold 157 Sarepta Therapeutics shares in Q4 2025, an estimated $3.02K.
  • Storebrand Asset Management first reported a position in Sarepta Therapeutics in Q1 2020 and held it in 23 quarters.
  • Storebrand Asset Management's Sarepta Therapeutics position peaked at $11.5M in Q4 2020.
  • 344 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2025.

Based on Storebrand Asset Management's 13F filing for Q4 2025, filed 20 May 2026.